Jinhua People's Hospital
12
7
7
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
42%
5 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)
Role: collaborator
Atrial Fibrillation Recurrence Prediction
Role: collaborator
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
Role: collaborator
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Role: collaborator
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Role: collaborator
Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma
Role: collaborator
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
Role: collaborator
The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke
Role: collaborator
Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke
Role: collaborator
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Role: collaborator
Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity
Role: collaborator
Prognostic Value of Plasma Thrombospondin-1 Levels After Acute Intracerebral Hemorrhage
Role: lead
All 12 trials loaded